跳至主要内容
临床试验/RBR-2chrm72
RBR-2chrm72尚未招募未知

Percutaneous Chevron-Akin technique for hallux valgus correction: is it necessary to fix the Akin? A randomized clinical trial

Instituto Prevent Senior0 个研究点开始时间: 2021年5月31日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Intervention

入排标准

年龄范围
16Y 至 0(—)

入选标准

  • Patients diagnosed with moderate or severe hallux valgus, with no improvement after six months of conservative treatment and who have agreed and signed the informed consent form.

排除标准

  • Patients with neuropathy, skin lesions, previous degenerative injuries to the ankle or previous surgeries on the ankle or foot, less than 16 years old, sequelae of fractures of the tibial pylon, ankle and foot. In addition, patients with collagen disorders, rheumatoid arthritis, seronegative arthritis will be excluded.

研究者

发起方
Instituto Prevent Senior

相似试验